Encounter Resources uncovers thick, high-grade niobium mineralisation at its Green prospect, signalling transformative potential for WA’s West Arunta region.
Lunnon Metals Lady Herial prospect in Kambalda delivers standout high-grade gold intercepts, showcasing near-surface open-pit potential and exploration upside.
Buxton Resources Graphite Bull project delivers exceptional high-grade results, including 50m at 24.9% TGC, solidifying its position in the booming battery materials market.
Island Pharmaceuticals (ASX: ILA) has secured a U.S. patent for its lead antiviral drug ISLA-101, targeting dengue fever and bolstering its intellectual property portfolio until 2034.
Apollo Minerals (ASX:AON) uncovers shallow high-grade gold at the Salanie Gold Project in Gabon, with results highlighting the untapped potential of this emerging discovery.
Argenica Therapeutics (ASX:AGN) has dosed 80% of patients in its Phase 2 trial for ARG-007, a promising stroke therapy, with no adverse safety concerns reported.
Variscan Mines triples the high-grade Mineral Resource Estimate at Novales-Udías to 3.4Mt @ 7.6% Zn, solidifying its position as a top-tier European zinc project.
China’s critical minerals export ban has opened a major opportunity for Australia to step up as a global supplier of essential materials like gallium, germanium, and antimony.
Trigg Minerals (ASX:TMG) is employing cutting-edge UAV geophysical technologies to unlock the mineral potential of the Wild Cattle Creek deposit, targeting critical minerals such as tungsten and antimony.
Warriedar Resources (ASX:WA8) uncovers high-grade antimony mineralisation at Azure Coast, enhancing the critical minerals potential of its Golden Range Project in Western Australia.